ATE408411T1 - USE OF POLYSACCHARIDE DERIVATIVES AS ANTI-INFECTIVE SUBSTANCES - Google Patents

USE OF POLYSACCHARIDE DERIVATIVES AS ANTI-INFECTIVE SUBSTANCES

Info

Publication number
ATE408411T1
ATE408411T1 AT03729214T AT03729214T ATE408411T1 AT E408411 T1 ATE408411 T1 AT E408411T1 AT 03729214 T AT03729214 T AT 03729214T AT 03729214 T AT03729214 T AT 03729214T AT E408411 T1 ATE408411 T1 AT E408411T1
Authority
AT
Austria
Prior art keywords
sub
group
alpha
alkyl
polysaccharide derivative
Prior art date
Application number
AT03729214T
Other languages
German (de)
Inventor
Vera Haack
Thomas Heinze
Michaela Schmidtke
Ute Moellmann
Hans-Martin Dahse
Albert Haertl
Original Assignee
Dow Wolff Cellulosics Gmbh
Univ Schiller Jena
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Wolff Cellulosics Gmbh, Univ Schiller Jena filed Critical Dow Wolff Cellulosics Gmbh
Application granted granted Critical
Publication of ATE408411T1 publication Critical patent/ATE408411T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/719—Pullulans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to a method of treating infectious diseases, that involves: (a) providing an alpha-glycosidically linked starch polysaccharide derivative; and (b) inhibiting the growth of an infectious disease by administering a composition comprising the alpha-glycosidically linked starch polysaccharide derivative. The alpha-glycosidically linked starch polysaccharide derivative represented by the following general formula I, in which: the alpha-glycosidically linked starch polysaccharide derivative has a degree of quaternary ammonium group substitution of from 0.4 to 2.0; n is 2-4; R<SUB>1 </SUB>is selected from the group consisting of C<SUB>1-4 </SUB>alkyl, benzyl and benzyl substituted with a member selected from the group consisting of C<SUB>1-3 </SUB>alkyl, halogen, alcoxy, carbamoyl, alkoxycarbonyl, cyano, dialkylamino and hydrogen; R<SUB>2 </SUB>and R<SUB>3 </SUB>are each independently selected from the group consisting of C<SUB>1-4 </SUB>alkyl, benzyl and benzyl substituted with a member selected from the group consisting of C<SUB>1-3 </SUB>alkyl, halogen, alcoxy, carbamoyl, alkoxycarbonyl, cyano and dialkylamino; and X is an anion selected from the group consisting of halide, hydroxide, sulfate, hydrogen sulfate and carboxylate.
AT03729214T 2002-01-10 2003-01-10 USE OF POLYSACCHARIDE DERIVATIVES AS ANTI-INFECTIVE SUBSTANCES ATE408411T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10200717A DE10200717A1 (en) 2002-01-10 2002-01-10 Use of polysaccharide derivatives as anti-infective substances

Publications (1)

Publication Number Publication Date
ATE408411T1 true ATE408411T1 (en) 2008-10-15

Family

ID=7711838

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03729214T ATE408411T1 (en) 2002-01-10 2003-01-10 USE OF POLYSACCHARIDE DERIVATIVES AS ANTI-INFECTIVE SUBSTANCES

Country Status (17)

Country Link
US (1) US7297687B2 (en)
EP (1) EP1465640B8 (en)
JP (1) JP4452777B2 (en)
KR (1) KR100913301B1 (en)
CN (1) CN1615141B (en)
AT (1) ATE408411T1 (en)
AU (1) AU2003210125B2 (en)
BR (1) BRPI0306851A8 (en)
CA (1) CA2472586C (en)
DE (2) DE10200717A1 (en)
ES (1) ES2314205T3 (en)
MX (1) MXPA04006673A (en)
NO (1) NO20043265L (en)
PL (1) PL206600B1 (en)
RU (1) RU2332221C2 (en)
WO (1) WO2003057227A1 (en)
ZA (1) ZA200405400B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060163149A1 (en) * 2003-06-13 2006-07-27 Torkel Wadstrom Product for absorption purposes
CN100469707C (en) * 2005-03-11 2009-03-18 中国石化北京燕化石油化工股份有限公司 A treatment method for high-turbidity high-speed railway circulating cooling water
KR101278106B1 (en) * 2011-03-03 2013-06-24 이원실 The preparation method of cellulose type polymer antimicrobial using ionic liquid
EP2822384A1 (en) 2012-03-09 2015-01-14 Friedrich-Schiller-Universität Jena Di- and multifunctional amine-modified oligo- and polysaccharide derivatives as anti-infective substances and the use thereof
US20170360040A1 (en) * 2014-12-02 2017-12-21 B.G. Negev Technologies And Applications Ltd., At Ben-Gurion University Modified polysaccharides for use as anti-microbial agents
FR3064473B1 (en) * 2017-04-03 2021-02-12 Basf Beauty Care Solutions France Sas PROTECTIVE INGREDIENT OF THE BALANCE OF SKIN AND / OR MUCOSAL MICROBIAL FLORA
CN112423771B (en) * 2018-07-20 2023-05-09 株式会社资生堂 virus inactivator
CN115260320B (en) * 2021-04-30 2023-05-05 中国科学院化学研究所 Use of ionic polysaccharide derivatives as anti-icing coating materials
KR102559540B1 (en) 2022-09-19 2023-07-25 문건희 Earth wall for earth wall system

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60203265A (en) * 1984-03-28 1985-10-14 ダイセル化学工業株式会社 Anti-blood coagulation polymer material
DE3711680A1 (en) * 1987-04-07 1988-10-27 Hoechst Ag AQUEOUS BIOCIDES CATIONIC PLASTIC DISPERSIONS AND THE USE THEREOF AS FUNGICIDES, BACTERICIDES AND ALGICIDES EQUIPMENT
DE3720555A1 (en) * 1987-06-22 1989-01-05 Henkel Kgaa USE OF INSOLUBLE, POLYFUNCTIONAL QUARTAINE AMMONIUM COMPOUNDS FOR ADSORPTIVE BINDING OF MICROORGANISMS
IT1231168B (en) * 1989-07-21 1991-11-22 Texcontor Ets SACCHARIDIC COPOLYMERS HAVING ANTIBACTERIAL ACTIVITY.
JPH0457969A (en) 1990-06-27 1992-02-25 Unitika Ltd Production of antibacterial fabric
US5731259A (en) * 1991-05-03 1998-03-24 Societa Consortile Ricerche Angelini S.P.A. Cationic polysaccharides
IT1249309B (en) * 1991-05-03 1995-02-22 Faricerca Spa CATIONIC TYPE POLYSACCHARIDES
GB2262531B (en) * 1991-12-17 1995-12-06 Erba Carlo Spa Antiviral sulphated polysaccharides
JPH05295002A (en) * 1992-04-23 1993-11-09 Nichiden Kagaku Kk Antibacterial starch, water-soluble polysaccharides and production thereof
ZA947572B (en) * 1993-09-29 1995-09-28 Hampton Roads Medical College Contraceptive compositions
RU2098114C1 (en) * 1995-02-03 1997-12-10 Музыка Владислав Иванович Preparation effecting the eucaryotic and procaryotic cell functional activity
JPH10155898A (en) * 1996-11-26 1998-06-16 Toyobo Co Ltd Antimicrobial property-imparting antithrombotic material
US6096291A (en) * 1996-12-27 2000-08-01 Biovector Therapeutics, S.A. Mucosal administration of substances to mammals
US6306835B1 (en) * 1997-09-23 2001-10-23 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Biocidal chitosan derivatives
EP0948960B1 (en) * 1998-04-09 2008-12-31 National Starch and Chemical Investment Holding Corporation Nonionically derivatized starches and their use in non-aerosol, low voc hair fixative compositions
WO2000026447A1 (en) * 1998-10-29 2000-05-11 Ciba Specialty Chemicals Holding Inc. Incorporation of organic anti-microbials into fibres during a fibre spinning process

Also Published As

Publication number Publication date
EP1465640A1 (en) 2004-10-13
AU2003210125A1 (en) 2003-07-24
CN1615141A (en) 2005-05-11
DE50310510D1 (en) 2008-10-30
ZA200405400B (en) 2005-11-30
KR100913301B1 (en) 2009-08-26
NO20043265L (en) 2004-08-04
CA2472586A1 (en) 2003-07-17
DE10200717A1 (en) 2003-07-31
EP1465640B1 (en) 2008-09-17
MXPA04006673A (en) 2004-11-10
CN1615141B (en) 2013-08-14
ES2314205T3 (en) 2009-03-16
BRPI0306851A8 (en) 2017-04-25
WO2003057227A1 (en) 2003-07-17
EP1465640B8 (en) 2009-04-01
AU2003210125B2 (en) 2008-01-24
PL206600B1 (en) 2010-08-31
RU2004124389A (en) 2005-05-10
US7297687B2 (en) 2007-11-20
CA2472586C (en) 2011-03-15
PL370887A1 (en) 2005-05-30
US20050054609A1 (en) 2005-03-10
JP4452777B2 (en) 2010-04-21
BRPI0306851A2 (en) 2016-11-16
RU2332221C2 (en) 2008-08-27
JP2005519057A (en) 2005-06-30
KR20040079415A (en) 2004-09-14

Similar Documents

Publication Publication Date Title
BR0316375A (en) Diazinopyrimidines
DE60019904D1 (en) USE OF SULPHATE DERIVATIVES FOR THE TREATMENT OF IMPULSE DISORDER
BRPI0507984A (en) compound or a salt thereof, process for producing a compound, medicament, methods for antagonizing angiotensin ii in a mammal, improving insulin resistance in a mammal, and preventing or treating circulatory disease in a mammal, and, use of the compound
DE60103995D1 (en) PERZYCHININE, METHOD FOR THE PRODUCTION THEREOF AND ITS USE AS A PHARMACEUTICAL PRODUCT
BRPI0406427B8 (en) process for preparing roflumilast
HRP20041042A2 (en) NEW SUBSTITUTED SULFAMATE DERIVATIVES AS ANTI-CONVULSIVES
MXPA05013752A (en) Process and intermediates for the preparation of (1r,2s,5s)-6,6-dimethyl-3-azabicyclo[3,1,0]hexane-2-carboxylates or salts thereof.
CY1106786T1 (en) N-[HETEROARYL(PIPERIDINO-2-YL)METHYL]BENZAMIDE DERIVATIVES, THEIR PREPARATION PROCESS AND THERAPEUTIC APPLICATION
DE602004024880D1 (en) AZETIDINCARBOXAMIDE DERIVATIVES FOR THE USE OF THE TREATMENT OF CB1-RECEPTOR-MEDIATED DISEASES
NO20075726L (en) Process for the synthesis of 6-alkylaminoquinoline derivatives
MY136686A (en) Salt forms of 3-(4-bromo-2,6-difluoro-benzyloxy)-5-[3-(4-pyrrolidin-1-yl-butyl)-ureido]-isothiazole-4-carboxylic acid amide and method of production
NO985864L (en) New anti-viral compounds
DE50310510D1 (en) USE OF POLYSACCHARIDE DERIVATIVES AS ANTI-INFECTIVE SUBSTANCES
IS2367B (en) Imidazole derivatives to adjust sodium channel
SE9903894D0 (en) Novel compounds
DE50311923D1 (en) UREETHANE-SUBSTITUTED ACYCLES, METHOD FOR THE PRODUCTION THEREOF, AND THEIR USE AS MEDICAMENTS
NO20050270L (en) New compounds, their use and manufacture
NO20044881L (en) Acyl-3-carboxyphenylurea derivatives, preparation method and use thereof
EA200800785A1 (en) 4-Aryl-1,4-DIHYDRO-3 (2H) -IZOHINOLINONINY and 4-Aryl-in-Service of the Commonwealth of Independent Companies on-line of the Republic of Tatarstan; ON THEIR BASIS AND METHOD OF TREATMENT OF DISEASES MEDIATED BY IGF-1 RECEPTOR
ATE423171T1 (en) USE OF CHINALDINE AND NAPHTHALINE DERIVATIVES AS CRYSTALIZATION MODIFIERS
ATE421961T1 (en) PIPERIDINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER&#39;S DISEASE CONTAINING THESE DERIVATIVES
NO20054418L (en) Substituted benzoylureidopyridylpiperidine and pyrrolidinecarboxylic acid derivatives, their preparation and use
CY1109717T1 (en) 5-PYRIDINYLIO-1-AZADICYLIC PRODUCT [3.2.1] OCTANE, METHOD OF PREPARATION AND ITS APPLICATION TO THERAPEUTIC
DE60224509D1 (en) IMIDAZOLE DERIVATIVES USE AS HISTAMINE H3 RECEPTOR LIGANDS
NO20053876D0 (en) Carbonylamino-substituted acylphenylurea derivatives, process for their preparation and use thereof

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee